Find More Contacts for Aratana Therapeutics
Protected Content
Non-Management Legal
1 email found
View contacts for Aratana Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Phone Number 913-951-2130

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial

products for companion animals in a cost effective and efficient manner.

Lists Featuring This Company

Acquired United States Companies (Top 10K)
9,749 Number of Organizations • $935.9B Total Funding Amount • 49,117 Number of Investors
Pharmaceutical Companies that Exited
4,510 Number of Organizations • $423.3B Total Funding Amount • 7,623 Number of Investors
MPM Capital Portfolio Companies
156 Number of Organizations • $30.9B Total Funding Amount • 1,445 Number of Investors
Kansas Companies that Exited
527 Number of Organizations • $8B Total Funding Amount • 183 Number of Investors
Aratana Therapeutics was acquired by Elanco for $245M on Apr 26, 2019.

Frequently Asked Questions

Where is Aratana Therapeutics's headquarters? Aratana Therapeutics is located in Leawood, Kansas, United States.Who invested in Aratana Therapeutics? Aratana Therapeutics has 14 investors including Cowen Investment Management and Oxford Finance LLC.How much funding has Aratana Therapeutics raised to date? Aratana Therapeutics has raised .When was the last funding round for Aratana Therapeutics? Aratana Therapeutics closed its last funding round on Mar 15, 2018 from a Post-IPO Equity round.Who are Aratana Therapeutics's competitors? Alternatives and possible competitors to Aratana Therapeutics may include Health IQObsidian Therapeutics, and Intarcia Therapeutics.